COO
NASD Cooper Companies, Inc.$56.57 ↑ +0.00 (+0.00%) Trading Up from the previous close of $56.57
- YTD change
- -30.98%
- vs 20-day SMA
- -5.13%
- vs 200-day SMA
- -21.29%
Price ranges
Price & Performance
-12.74 (-18.38%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 87.8% away from all-time highs of $463.59
- COO is down 31% since the beginning of the year
- COO is down 16% over the past 12 months
- COO is down 21% over the past 1 month
- 5% of all COO investors are betting against COO
COO reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -16.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.37
- Last 5 days
- +4.53%
- vs 8-day SMA
- +2.42%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
The Cooper Cos, Inc. operates as a medical device company. It operates through the CooperVision and CooperSurgical segments. The CooperVision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The CooperSurgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
